{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:06:59Z","timestamp":1792789619971,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["118695"],"award-info":[{"award-number":["118695"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P50 DK096418"],"award-info":[{"award-number":["P50 DK096418"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00467-023-06007-8","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T16:02:57Z","timestamp":1687795377000},"page":"269-282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7278-3137","authenticated-orcid":false,"given":"Hayton","family":"Chui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrad Rod","family":"Rassekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom D.","family":"Blydt-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maury","family":"Pinsk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D. E.","family":"Cuvelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce C.","family":"Carleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross T.","family":"Tsuyuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J. D.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Devarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Yordanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rik","family":"Cr\u00e9peau-Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedran","family":"Cockovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Palijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zappitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Applying Biomarkers to Minimize Long-Term Effects of Childhood\/Adolescent Cancer Treatment (ABLE) Research Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Laverdi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Michon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raveena","family":"Ramphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sabapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"6007_CR1","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.0.CO;2-M","volume":"88","author":"KC Oeffinger","year":"2000","unstructured":"Oeffinger KC, Eshelman DA, Tomlinson GE, Buchanan GR, Foster BM (2000) Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 88:1687\u20131695","journal-title":"Cancer"},{"key":"6007_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1053\/jpdn.2003.13","volume":"18","author":"SJ Bottomley","year":"2003","unstructured":"Bottomley SJ, Kassner E (2003) Late effects of childhood cancer therapy. J Pediatr Nurs 18:126\u2013133","journal-title":"J Pediatr Nurs"},{"key":"6007_CR3","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL, Childhood Cancer Survivor Study (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572\u20131582","journal-title":"N Engl J Med"},{"key":"6007_CR4","doi-asserted-by":"crossref","unstructured":"Fujieda M, Matsunaga A, Hayashi A, Tauchi H, Chayama K, Sekine T (2009) Children\u2019s toxicology from bench to bed--drug-induced renal injury (2): nephrotoxicity induced by cisplatin and ifosfamide in children. J Toxicol Sci 34(Suppl 2):SP251\u2013S257","DOI":"10.2131\/jts.34.SP251"},{"key":"6007_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U","volume":"28","author":"G Ariceta","year":"1997","unstructured":"Ariceta G, Rodriguez-Soriano J, Vallo A, Navajas A (1997) Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis. Med Pediatr Oncol 28:35\u201340","journal-title":"Med Pediatr Oncol"},{"key":"6007_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00253068","volume":"18","author":"MP Goren","year":"1986","unstructured":"Goren MP, Wright RK, Horowitz ME (1986) Cumulative renal tubular damage associated with cisplatin nephrotoxicity. Cancer Chemother Pharmacol 18:69\u201373","journal-title":"Cancer Chemother Pharmacol"},{"key":"6007_CR7","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s00467-018-3976-5","volume":"33","author":"KR McMahon","year":"2018","unstructured":"McMahon KR, Harel-Sterling M, Pizzi M, Huynh L, Hessey E, Zappitelli M (2018) Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study. Pediatr Nephrol 33:2311\u20132320","journal-title":"Pediatr Nephrol"},{"key":"6007_CR8","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","volume":"45","author":"R Skinner","year":"2009","unstructured":"Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD (2009) Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors. Eur J Cancer 45:3213\u20133219","journal-title":"Eur J Cancer"},{"key":"6007_CR9","first-page":"S30","volume":"18","author":"R Skinner","year":"1992","unstructured":"Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW (1992) The influence of age on nephrotoxicity following chemotherapy in children. Br J Cancer 18:S30\u2013S35","journal-title":"Br J Cancer"},{"key":"6007_CR10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0272-6386(98)70074-5","volume":"32","author":"CA Jones","year":"1998","unstructured":"Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY (1998) Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 32:992\u2013999","journal-title":"Am J Kidney Dis"},{"key":"6007_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","volume":"40","author":"VR Dharnidharka","year":"2002","unstructured":"Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221\u2013226","journal-title":"Am J Kidney Dis"},{"key":"6007_CR12","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/cc12503","volume":"17","author":"K Kashani","year":"2013","unstructured":"Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmele T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25","journal-title":"Crit Care"},{"key":"6007_CR13","doi-asserted-by":"crossref","unstructured":"Meersch M, Schmidt C, Van Aken H, Rossaint J, Gorlich D, Stege D, Malec E, Januszewska K, Zarbock A (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery. PLoS One 9:e110865","DOI":"10.1371\/journal.pone.0110865"},{"key":"6007_CR14","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1164\/rccm.201401-0077OC","volume":"189","author":"A Bihorac","year":"2014","unstructured":"Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Fitzgerald R, Gong MN, Graham DD, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner JL, Krell K, Letourneau J, Lissauer M, Miner J, Nguyen HB, Ortega LM, Self WH, Sellman R, Shi J, Straseski J, Szalados JE, Wilber ST, Walker MG, Wilson J, Wunderink R, Zimmerman J, Kellum JA (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189:932\u2013939","journal-title":"Am J Respir Crit Care Med"},{"key":"6007_CR15","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/ndt\/gfu292","volume":"29","author":"EA Hoste","year":"2014","unstructured":"Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, Feldkamp T, Uettwiller-Geiger DL, McCarthy P, Shi J, Walker MG, Kellum JA (2014) Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 29:2054\u20132061","journal-title":"Nephrol Dial Transplant"},{"key":"6007_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/IJNRD.S135271","volume":"10","author":"M Schanz","year":"2017","unstructured":"Schanz M, Hoferer A, Shi J, Alscher MD, Kimmel M (2017) Urinary TIMP2IGFBP7 for the prediction of platinum-induced acute renal injury. Int J Nephrol Renovasc Dis 10:175\u2013181","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"6007_CR17","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41390-019-0698-8","volume":"87","author":"J Chen","year":"2019","unstructured":"Chen J, Sun Y, Wang S, Dai X, Huang H, Bai Z, Li X, Wang J, Li Y (2019) The effectiveness of urinary TIMP-2 and IGFBP-7 in predicting acute kidney injury in critically ill neonates. Pediatr Res 87:1052\u20131059","journal-title":"Pediatr Res"},{"key":"6007_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrneph.2016.19","volume":"12","author":"CL Abitbol","year":"2016","unstructured":"Abitbol CL, Moxey-Mims M (2016) Chronic kidney disease: low birth weight and the global burden of kidney disease. Nat Rev Nephrol 12:199\u2013200","journal-title":"Nat Rev Nephrol"},{"key":"6007_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ndt\/gfx016","volume":"32","author":"C Ronco","year":"2017","unstructured":"Ronco C, Rizo-Topete L, Serrano-Soto M, Kashani K (2017) Pro: prevention of acute kidney injury: time for teamwork and new biomarkers. Nephrol Dial Transplant 32:408\u2013413","journal-title":"Nephrol Dial Transplant"},{"key":"6007_CR20","unstructured":"Department of Health and Human Services (2014) US Food and Drug Administration. Letter to Astute Medical, Inc"},{"key":"6007_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jinf.2009.04.003","volume":"58","author":"Q-h Yang","year":"2009","unstructured":"Yang Q-h, Liu D-w, Long Y, Liu H-z, Chai W-z, Wang X-T (2009) Acute renal failure during sepsis: potential role of cell cycle regulation. J Infect 58:459\u2013464","journal-title":"J Infect"},{"key":"6007_CR22","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1172\/JCI117214","volume":"93","author":"R Witzgall","year":"1994","unstructured":"Witzgall R, Brown D, Schwarz C, Bonventre JV (1994) Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93:2175\u20132188","journal-title":"J Clin Invest"},{"key":"6007_CR23","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1093\/nar\/gkm744","volume":"35","author":"F Rodier","year":"2007","unstructured":"Rodier F, Campisi J, Bhaumik D (2007) Two faces of p53: aging and tumor suppression. Nucleic Acids Res 35:7475\u20137484","journal-title":"Nucleic Acids Res"},{"key":"6007_CR24","doi-asserted-by":"publisher","first-page":"e203639","DOI":"10.1001\/jamanetworkopen.2020.3639","volume":"3","author":"KR McMahon","year":"2020","unstructured":"McMahon KR, Rassekh SR, Schultz KR, Blydt-Hansen T, Cuvelier GDE, Mammen C, Pinsk M, Carleton BC, Tsuyuki RT, Ross CJD, Palijan A, Huynh L, Yordanova M, Crepeau-Hubert F, Wang S, Boyko D, Zappitelli M, Applying Biomarkers to Minimize Long-term Effects of Childhood\/Adolescent Cancer Treatment Research Study Group (2020) Epidemiologic characteristics of acute kidney injury during cisplatin infusions in children treated for cancer. JAMA Netw Open 3:e203639","journal-title":"JAMA Netw Open"},{"key":"6007_CR25","doi-asserted-by":"publisher","first-page":"205435811769033","DOI":"10.1177\/2054358117690338","volume":"4","author":"KR McMahon","year":"2017","unstructured":"McMahon KR, Rod Rassekh S, Schultz KR, Pinsk M, Blydt-Hansen T, Mammen C, Tsuyuki RT, Devarajan P, Cuvelier GD, Mitchell LG, Baruchel S, Palijan A, Carleton BC, Ross CJ, Zappitelli M, Applying Biomarkers to Minimize Long-Term Effects of Childhood\/Adolescent Cancer Treatment Research Group (2017) Design and methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood\/Adolescent Cancer Treatment (ABLE) nephrotoxicity study: a prospective observational cohort study. Can J Kidney Health Dis 4:2054358117690338","journal-title":"Can J Kidney Health Dis"},{"key":"6007_CR26","doi-asserted-by":"publisher","unstructured":"McMahon KR, Chui H, Rassekh SR, Schultz KR, Blydt-Hansen TD, Mammen C, Pinsk M, Cuvelier GDE, Carleton BC, Tsuyuki RT, Ross CJD, Devarajan P, Huynh L, Yordanova M, Crepeau-Hubert F, Wang S, Cockovski V, Palijan A, Zappitelli M (2021) Urine neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 to detect pediatric cisplatin-associated acute kidney injury. Kidney 360(3):37\u201350.\u00a0https:\/\/doi.org\/10.34067\/KID.0004802021","DOI":"10.34067\/KID.0004802021"},{"key":"6007_CR27","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00467-017-3748-7","volume":"32","author":"L Dong","year":"2017","unstructured":"Dong L, Ma Q, Bennett M, Devarajan P (2017) Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass. Pediatr Nephrol 32:2351\u20132360","journal-title":"Pediatr Nephrol"},{"key":"6007_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1\u2013138","journal-title":"Kidney Int Suppl"},{"key":"6007_CR29","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1200\/JCO.2017.75.7161","volume":"36","author":"SS Motwani","year":"2018","unstructured":"Motwani SS, McMahon GM, Humphreys BD, Partridge AH, Waikar SS, Curhan GC (2018) Development and validation of a risk prediction model for acute kidney injury after the first course of cisplatin. J Clin Oncol 36:682\u2013688","journal-title":"J Clin Oncol"},{"key":"6007_CR30","unstructured":"(2010) Common terminology criteria for adverse events (CTCAE), Version 4.0. National Institutes of Health National Cancer Institute, pp 1\u2013194"},{"key":"6007_CR31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837\u2013845","journal-title":"Biometrics"},{"key":"6007_CR32","doi-asserted-by":"crossref","unstructured":"Bojan M, Pieroni L, Semeraro M, Froissart M (2020) Cell-cycle arrest biomarkers: usefulness for cardiac surgery-related acute kidney injury in neonates and infants. Pediatr Crit Care Med 21:563\u2013570","DOI":"10.1097\/PCC.0000000000002270"},{"key":"6007_CR33","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1681\/ASN.2010111163","volume":"22","author":"CR Parikh","year":"2011","unstructured":"Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, Kim RW, Koyner JL, Coca SG, Edelstein CL, Shlipak MG, Garg AX, Krawczeski CD, TRIBE-AKI Consortium (2011) Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22:1737\u20131747","journal-title":"J Am Soc Nephrol"},{"key":"6007_CR34","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2215\/CJN.10971012","volume":"8","author":"CR Parikh","year":"2013","unstructured":"Parikh CR, Thiessen-Philbrook H, Garg AX, Kadiyala D, Shlipak MG, Koyner JL, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Coca SG, TRIBE-AKI Consortium (2013) Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol 8:1079\u20131088","journal-title":"Clin J Am Soc Nephrol"},{"key":"6007_CR35","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/cc6089","volume":"11","author":"M Zappitelli","year":"2007","unstructured":"Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL (2007) Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 11:R84","journal-title":"Crit Care"},{"key":"6007_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","volume":"365","author":"J Mishra","year":"2005","unstructured":"Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231\u20131238","journal-title":"Lancet"},{"key":"6007_CR37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/sj.ki.5002715","volume":"73","author":"WK Han","year":"2008","unstructured":"Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV (2008) Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 73:863\u2013869","journal-title":"Kidney Int"},{"key":"6007_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ki.2010.200","volume":"78","author":"SL Goldstein","year":"2010","unstructured":"Goldstein SL (2010) Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not? Kidney Int 78:433\u2013435","journal-title":"Kidney Int"},{"key":"6007_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1681\/ASN.2011040325","volume":"23","author":"AM Ralib","year":"2012","unstructured":"Ralib AM, Pickering JW, Shaw GM, Devarajan P, Edelstein CL, Bonventre JV, Endre ZH (2012) Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 23:322\u2013333","journal-title":"J Am Soc Nephrol"},{"key":"6007_CR40","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s11255-017-1556-4","volume":"49","author":"Z Toprak","year":"2017","unstructured":"Toprak Z, Cebeci E, Helvaci SA, Toprak ID, Kutlu Y, Sakin A, Tukek T (2017) Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients. Int Urol Nephrol 49:1041\u20131047","journal-title":"Int Urol Nephrol"},{"key":"6007_CR41","doi-asserted-by":"crossref","unstructured":"Westhoff JH, Tonshoff B, Waldherr S, Poschl J, Teufel U, Westhoff TH, Fichtner A (2015) Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) * insulin-like growth factor-binding protein 7 (IGFBP7) predicts adverse outcome in pediatric acute kidney injury. PLoS One 10:e0143628","DOI":"10.1371\/journal.pone.0143628"},{"key":"6007_CR42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12887-018-1175-y","volume":"18","author":"Z Bai","year":"2018","unstructured":"Bai Z, Fang F, Xu Z, Lu C, Wang X, Chen J, Pan J, Wang J, Li Y (2018) Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children. BMC Pediatr 18:192","journal-title":"BMC Pediatr"},{"key":"6007_CR43","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00467-017-3655-y","volume":"32","author":"KM Gist","year":"2017","unstructured":"Gist KM, Goldstein SL, Wrona J, Alten JA, Basu RK, Cooper DS, Soranno DE, Duplantis J, Altmann C, Gao Z, Faubel S (2017) Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery. Pediatr Nephrol 32:1611\u20131619","journal-title":"Pediatr Nephrol"},{"key":"6007_CR44","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2217\/bmm-2019-0419","volume":"14","author":"H Chui","year":"2020","unstructured":"Chui H, Caldwell J, Yordanova M, Cockovski V, Fredric D, Harel-Sterling M, Haasz M, Al-Ismaili Z, Pizzi M, Ma Q, Devarajan P, Goldstein SL, Zappitelli M (2020) Tubular injury and cell-cycle arrest biomarkers to predict acute kidney injury in noncritically ill children receiving aminoglycosides. Biomark Med 14:879\u2013894","journal-title":"Biomark Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-06007-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T11:05:03Z","timestamp":1700823903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-06007-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6007"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-06007-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Approval was granted by the Pediatrics Research Ethics Board of the McGill University Health Centre (12\u2013301-PED).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent and assent if appropriate were obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}